DEADLINE ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Amicus Therapeutics, Inc. & Encourages Invest...
November 26 2015 - 09:45PM
Business Wire
Lundin Law PC announces a class action lawsuit has been filed
against Amicus Therapeutics, Inc. (“Amicus” or the “Company”)
(FOLD) concerning possible violations of federal securities laws
between September 15, 2015 and October 1, 2015. Investors who
purchased or otherwise acquired shares during the Class Period
should contact the Firm in advance of the December 7, 2015, lead
plaintiff motion deadline.
To participate in this class action lawsuit, please contact
Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or via
e-mail at brian@lundinlawpc.com.
According to the complaint, on October 2, 2015, Amicus announced
that after meeting with FDA officials, the Company does not
anticipate being able to submit a new drug application (NDA) for
migalastat, the company's Fabry disease treatment, by the end of
the year. When the truth was revealed, shares dropped, harming
investors.
No class has been certified in the above action. Until a class
is certified, you are not considered represented by an attorney.
You may also choose to do nothing and be an absent class
member.
Lundin Law PC was created by Brian Lundin, a securities
litigator based in Los Angeles.
This press release may be considered Attorney Advertising in
some jurisdictions under the applicable law and ethical rules.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20151126005540/en/
Lundin Law PCBrian Lundin, Esq.Telephone: 888-713-1033Facsimile:
888-713-1125brian@lundinlaw.com
Amicus Therapeutics (NASDAQ:FOLD)
Historical Stock Chart
From Feb 2024 to Mar 2024
Amicus Therapeutics (NASDAQ:FOLD)
Historical Stock Chart
From Mar 2023 to Mar 2024